086900 · Medy-Tox Inc.

67900.00

KRW

3200.00 (4.95%)

16/10/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

KRW472.21B

50.90

EV/EBITDA

22.6

DIV Yield

1%

Payout Ratio

51%

MQV Rating

5Very Weak

As at 16/10/2026 12:00:00 AM

Price Chart

Description

Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongwon-gun, South Korea.

All-Companies
All-Consensus
HALO All

Key Fundamentals

EPS 3 yr Growth

-56.80%

EBITDA Margin

14.80%

Operating Cashflow

₩61,481m

Free Cash Flow Return

12.80%

ROIC

3.50%

Interest Coverage

56.40

Quick Ratio

1.10

Performance

52 weeks range

Low 61600 - 141100

Trade Value (12mth)

US$766,270.00

1 week

-4.15%

1 month

-7.04%

YTD

-47.14%

1 year

-45.99%

All time high

700092.00

Additional Data

Shares Outstanding (Fully Diluted)

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

28-Oct-26

Next Dividend Pay Date

09-Nov-26

Reporting Currency

KRW

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Weak

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Hyun-Ho Jeong	Individual
Medy-Tox, Inc.	Public Company
Dominus Investment Co., Ltd.	Private Company
Gyeong-hee Park	Individual
Young-Ik Cheon	Individual